Anders Lindvall – Advisor

Anders Lindvall was born in the city of Sundsvall, Sweden, in 1942. After graduation from high school in 1960 he served in the Swedish Air Force for 1½ years. In 1962 – 1967 he completed his Master of Science in Engineering at the Lund Institute of Technology, Sweden. During this time he also ran a project at the Dept. of Neurophysiology at Lund University Hospital, Sweden. In 1967 he entered a medical education program at the University of Lund. A two years stay at the University of California Los Angeles (UCLA) was incorporated in the program. At UCLA he studied biomathematics (Prof. Carol Newton) and telemetry transmission, recording and analyses techniques of EEG.s at the Space Biology Laboratory (Prof. John Hanley, Brain Research Institute). After his MD-degree in 1976 he served his internship followed by a staff position at the Dept. of Infectious Diseases, University Hospital in Uppsala, Sweden. He then investigated the role of a Herpes virus (Epstein-Barr) in the chronic fatigue syndrome (CFS/ME). He was head of the Dept. of Clinical Metal Biology at the University Hospital 1989-2000. He then, in cooperation with prof. Ulf Lindh, investigated the cellular uptake and distribution of metals in chronic diseases, especially in CFS/ME. During 1992-2005 he was part of a research team at the Center for Metal Biology (Prof. Ulf Lindh) in Uppsala to evaluate selected methods of detoxification from heavy metal overload. Since 1994 he has been part owner and CEO of MediMetal AB (MM). The company has been active in international projects in the field of Ship Recycling, under the leadership of Dr George Kinigalakis (part owner of MM, as are Ulf Lindh and Olle Selinus). From 2005 Dr Lindvall has been engaged as medical consultant on a continuous basis to providers of medical care in Stockholm County and, from 2017, also in Uppsala. He resides in Uppsala, has a wife and two grown-up children.

Published articles

  1. Johnsson A, Lindvall A. Effects of low-intensity ultrasound on viscous properties of Helodea cells. Die Naturwissenschaften 1969; 01-40.
  2. Grandien M, Lindvall A, Bohlin A-B. RS-virusinfektioner – drabbar yngst och äldst. Läkartidningen 1984; 11: 1021-3.
  3. Lindvall A, Sjölin J, Cullhed I, Friman G. Rheumatisk feber – en sällsynthet. Läkartidningen 1987; 51: 4343-5.
  4. Linde A, Kallin B, Dillner J, Andersson J, Jägdahl L, Lindvall A, Wahren B. Evaluation of Enzyme-Linked Immunosorbent Assays with two synthetic peptides of Epstein-Barr virus för diagnosis of infectious mononucleosis. Journal of Infectious Diseases 1990; 161: 903-9.
  5. Linde A,Andersson B, Svensson SB, Ahrne H, Carlsson M, Forsberg P, Hugo H, Karstorp A, Lenkei R, Lindvall A, Loftenius A, Säil C, Andersson J. Serum Levels of Lymphokines and Soluble Cellular Receptors in Primary Epstein-Barr Virus Infection and in Patients with Chronic Fatigue Syndrome. The Journal of Infectious Diseases 1992; 165: 994–1000.
  6. Stejskal V, Cederbrant K, Lindvall A, Forsbeck MELISA – an in vitro tool for the study of metal allergy. Toxicology in Vitro 1994; 8: 991-1000.
  7. Stejskal V, Cederbrant K, Lindvall A, Forsbeck M. Mercury specific lymphocytes: an indication of mercury allergy in man. J Clin Immunol 1996; 16: 31-40.
  8. Lindh U, Danersund A, Lindvall A. Selenium protection against toxicity from cadmium and mercury studied at the cellular level. Cellular and Molecular Biology 1996: 42: 39-48.
  9. Lindh U, Frisk P, Nystrom J, Danersund A, Hudecek R, Lindvall A, Thunell S. Nuclear microscopy in biomedical analysis with special emphasis on clinical metal biology. Nucl Instr and Meth 1997; B130: 406-18.
  • Danersund A, Hudecek R, Lindvall A, Stejskal V, Lindh U. Experiences from the Department of Clinical Metal Biology at Uppsala University Hospital, 1990-97. Amalgam and Health – New perspective on risks. Ed. Novakova V. The Swedish Council for Planning and Coordination of Research, Stockholm 1999; 1: 67-77.
  • Hudecek R, Danersund A, Kinigalakis G, Lindvall A. Experiences of medical odontological treatment: Removal of incompatible dental materials (RID) in patients with intolerance of Dental material. Amalgam and Health – New perspective on risks. Ed Novakova V. The Swedish Council for Planning and Coordination of Research, Stockholm 1999; 1: 78-84.
  • Stejskal V, Danersund A, Lindvall A, Hudecek R, Nordman V, Yacob B, Meyer W, Bieger W, Lindh U. Metal-specific memory lymphocytes: Biomarkers of sensitivity in man. Neuro endocrinol Lett 1999; 20: 289-98.
  • Lindh U, Carlmark B, Gronquist SO, Lindvall A. Metal Exposure from Amalgam Alters the Distribution of Trace Elements in Blood Cells and Plasma. Clin Chem Lab Med 2001; 39(2): 134-42.
  • Lindh U, Hudecek R, Danersund A, Eriksson S, Lindvall A. Removal of dental amalgam and other metal alloys supported by antioxidant therapy alleviates symptoms and improves quality of life in patients with amalgam-associated ill health. Neuro endocrinol Lett 2002; 23: 459-82.
  • Yaqob A, Danersund A, Stejskal V, Lindvall A, Ulf Lindh. Metal-specific lymphocyte reactivity is downregulated after dental metal replacement. Neuro endocrinol Lett 2006.
  • Hylander L, Lindvall A, Gahnberg L. High mercury emissions from dental clinics despite amalgam separators. Science of the Total Environment July 2006.
  • Hylander L, Lindvall A, Uhrberg R, Gahnberg L, Lindh U. Mercury recovery in situ of four different dental amalgam separators. Science of The Total Environment aug 2006.
  • Frisk P, Lindvall A, Hudecek R, Lindh U. Decrease of Trace Elements in Erythrocytes and Plasma after Removal of Dental Amalgam and Other Metal Alloys. Biological Trace Element Research Jan 2007.